Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FEDRATINIB HYDROCHLORIDE, with a corresponding US DMF Number 37888.
Remarkably, this DMF maintains an Active status since its submission on March 22, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 09, 2023, and payment made on January 31, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II